Bank of New York Mellon’s Metacrine, Inc. Common Stock MTCR Stock Holding History
Bought
Maintained
Sold
Other funds holding MTCR
BCM
JC
AG
WS
Bank of New York Mellon's MTCR Position: Q1 2023 in Review
Bank of New York Mellon sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 204,023 shares — an estimated $91.4K sold.
Bank of New York Mellon first reported a position in MTCR in Q1 2021 and held it in 5 quarters. The position peaked at $126K in Q1 2022. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.
- Bank of New York Mellon reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Bank of New York Mellon sold 204,023 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $91.4K.
- Bank of New York Mellon first reported a position in Metacrine, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
- Bank of New York Mellon's Metacrine, Inc. Common Stock position peaked at $126K in Q1 2022.
- 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.